Su Wang, MD, MPH, FACP is the Medical Director of Viral Hepatitis Programs and the Center for Asian Health at the Cooperman Barnabas Medical Center, part of the RWJBarnabas Health System in New Jersey.
Dr. Wang is a practicing internist with a focus on viral hepatitis. She has served as primary investigator for a number of viral hepatitis screening and linkage-to-care studies sponsored by the US CDC and other funders. Dr, Wang has led primary care-based hepatitis B and C programs, community screening and outreach efforts, patient and community-based advocacy, and community based research initiatives.
She serves as Senior Advisor for Global Health for the Hepatitis B Foundation. She was also Past President of the World Hepatitis Alliance, an NGO committed to viral hepatitis elimination by harnessing the power of people living with hepatitis. Dr. Wang has served on a number of WHO guideline development committees including the 2024 " Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection."
She received her Medical Degree from the University of Miami and her Masters of Public Health from Johns Hopkins School of Public Health. Dr. Wang completed a combined Internal Medicine and Pediatric residency at Georgetown University Hospital and then served as an Epidemic Intelligence Service officer for the Centers for Disease Control and Prevention (CDC) at the US Food and Drug Administration (FDA). She was previously the Director of Hepatitis Programs at the Charles B. Wang Community Health Center in New York City.